Methods and compositions for isolating metastatic cancer cells, and use in measuring metastatic potential of a cancer thereof
View Patent ↗The present invention relates to novel methods and compositions for detection and isolation of cancer cells with metastatic potential. The invention further relates to assays for measuring the metastatic potential of such cancer cells and drug screening assays for the identification of agents having anti-metastatic potential. The present invention further provides methods and compositions for inhibiting the metastatic potential of cancer cells by modulating the activity of serine integral membrane proteases [(SIMP) consisting of seprase and dipetidyl peptidase IV (DPPIV)] expressed on the surface of metastasizing cancer cells.
1. A method for removal of cancer cells from a blood fluid containing a mixed population of cancer and non-cancer cells, said fluid selected from the group consisting of whole blood, lymph, bone marrow, ascites or a combination thereof, said method comprising
a) contacting said fluid with a cell-adhesion matrix coated with an adhesion molecule for a sufficient amount of time to permit the adherence of cancer cells to the cell-adhesion matrix, said matrix comprising a fibrous scaffold comprising type I collagen fibers, type III collagen fibers, fibrin, cotton fibers, tissue fragment, or plastic fibers;
b) incubating the mixed population of cells for a time sufficient to allow said cancer cells to ingest the matrix; and
c) isolating said cancer cells that ingested the matrix from cells that did not ingest the matrix, wherein said isolating step has a level of sensitivity of one viable cancer cell per ml of blood fluid.
2. A method for removal of cancer cells from blood containing a mixed population of cancer and non-cancer cells, said method comprising
a) contacting said blood with a cell adhesion matrix coated with an adhesion molecule for a sufficient amount of time to permit the adherence of cancer cells to the matrix, said matrix comprising a fibrous scaffold comprising type I collagen fibers, type III collagen fibers, fibrin, cotton fibers, tissue fragment, or plastic fibers;
b) incubating the cancer cells for a time sufficient to allow said cancer cells to ingest the matrix; and
c) isolating said cancer cells that ingested the matrix from cells that did not ingest the matrix, wherein said isolating step has a level of sensitivity of one viable cancer cell per ml of blood.
3. The method of claim 2 wherein the blood sample from which the cancer cells have been removed is reintroduced into the subject.
4. A method for removal of cancer cells from bone marrow fluid containing a mixed population of cancer and non-cancer cells, said method comprising
a) contacting said bone marrow with a cell-adhesion matrix coated with an adhesion molecule for a sufficient amount of time to permit the adherence of cancer cells to the cell-adhesion matrix, said matrix comprising a fibrous scaffold comprising type I collagen fibers, type III collagen fibers, fibrin, cotton fibers, tissue fragment, or plastic fibers;
b) incubating the cancer cells for a time sufficient to allow said cancer cells to ingest the matrix; and
c) isolating said cancer cells that ingested the matrix from cells that did not ingest the matrix, wherein said isolating step has a level of sensitivity of one viable cancer cell per ml of bone marrow fluid.
5. The method of claim 4 wherein the bone marrow from which the cancer cells have been removed is reintroduced into the subject.
6. The method of claim 1 , wherein said matrix is labeled, and wherein said cancer cells that ingest said matrix are thereby labeled.
7. The method of claim 2 , wherein said matrix is labeled, and wherein said cancer cells that ingest said matrix are thereby labeled.
8. The method of claim 4 , wherein said matrix is labeled, and wherein said cancer cells that ingest said matrix are thereby labeled.
9. The method of claim 1 , wherein said matrix further comprises a cytotoxin, and wherein said cancer cells that ingest said matrix are killed by said cytotoxin.
10. The method of claim 2 , wherein said matrix further comprises a cytotoxin, and wherein said cancer cells that ingest said matrix are killed by said cytotoxin.
11. The method of claim 4 , wherein said matrix further comprises a cytotoxin, and wherein said cancer cells that ingest said matrix are killed by said cytotoxin.
12. The method of claim 1 , wherein the removed cancer cells are viable.
13. The method of claim 2 , wherein the removed cancer cells are viable.
14. The method of claim 4 , wherein the removed cancer cells are viable.